Aclarion (ACONW) Competitors $0.04 +0.01 (+43.93%) (As of 08:08 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrends ACONW vs. AVHIW, AVHIU, AONC, BTTX, DHACW, CORBF, LFMDP, OTRKP, PIIIW, and SHCRWShould you be buying Aclarion stock or one of its competitors? The main competitors of Aclarion include Achari Ventures Holdings Corp. I (AVHIW), Achari Ventures Holdings Corp. I (AVHIU), American Oncology Network (AONC), Better Therapeutics (BTTX), Digital Health Acquisition (DHACW), Global Cord Blood (CORBF), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), and Sharecare (SHCRW). These companies are all part of the "healthcare" industry. Aclarion vs. Achari Ventures Holdings Corp. I Achari Ventures Holdings Corp. I American Oncology Network Better Therapeutics Digital Health Acquisition Global Cord Blood LifeMD Ontrak P3 Health Partners Sharecare Achari Ventures Holdings Corp. I (NASDAQ:AVHIW) and Aclarion (NASDAQ:ACONW) are both financial services companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, valuation, earnings, analyst recommendations, profitability, risk, community ranking and dividends. Does the media prefer AVHIW or ACONW? In the previous week, Aclarion had 1 more articles in the media than Achari Ventures Holdings Corp. I. MarketBeat recorded 1 mentions for Aclarion and 0 mentions for Achari Ventures Holdings Corp. I. Achari Ventures Holdings Corp. I's average media sentiment score of 0.00 equaled Aclarion'saverage media sentiment score. Company Overall Sentiment Achari Ventures Holdings Corp. I Neutral Aclarion Neutral Which has higher earnings & valuation, AVHIW or ACONW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAchari Ventures Holdings Corp. IN/AN/AN/AN/AN/AAclarion$49.29KN/AN/AN/AN/A Is AVHIW or ACONW more profitable? Company Net Margins Return on Equity Return on Assets Achari Ventures Holdings Corp. IN/A N/A N/A Aclarion N/A N/A N/A Does the MarketBeat Community favor AVHIW or ACONW? Achari Ventures Holdings Corp. I and Aclarion both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformAchari Ventures Holdings Corp. IN/AN/AAclarionN/AN/A SummaryAclarion beats Achari Ventures Holdings Corp. I on 2 of the 2 factors compared between the two stocks. Ad WealthPressBreaking News: Tesla headed to $500…That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. Get Aclarion News Delivered to You Automatically Sign up to receive the latest news and ratings for ACONW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACONW vs. The Competition Export to ExcelMetricAclarionHealth Information Services IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$177.91M$5.07B$8.80BDividend YieldN/A6.51%4.99%4.07%P/E RatioN/A697.7689.5613.60Price / SalesN/A304.691,224.8087.40Price / CashN/A39.8439.4536.27Price / BookN/A4.626.976.33Net IncomeN/A-$7.17M$119.04M$225.93M7 Day PerformanceN/A-1.13%-1.78%-0.96%1 Month PerformanceN/A1.39%-3.59%1.06%1 Year PerformanceN/A0.26%31.64%26.59% Aclarion Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACONWAclarionN/A$0.04+43.9%N/AN/A$0.00$49,289.000.007Gap UpAVHIWAchari Ventures Holdings Corp. IN/A$0.01flatN/AN/A$0.00N/A0.003AVHIUAchari Ventures Holdings Corp. IN/A$10.00flatN/AN/A$0.00N/A0.003AONCAmerican Oncology NetworkN/A$4.29+2.6%N/A-33.8%$0.00$1.34B0.001,520BTTXBetter TherapeuticsN/AN/AN/AN/A$0.00N/A0.0040Gap DownDHACWDigital Health AcquisitionN/A$0.03flatN/A+77.3%$0.00N/A0.00N/ACORBFGlobal Cord BloodN/A$1.25flatN/A+0.0%$0.00$196.12M0.001,202LFMDPLifeMDN/A$22.00flatN/A+18.9%$0.00$193.06M0.00230OTRKPOntrakN/A$0.28-35.3%N/A-11.3%$0.00$10.84M0.00250Gap DownPIIIWP3 Health PartnersN/A$0.02flatN/A-88.0%$0.00$1.48B0.00500SHCRWSharecareN/A$0.09flatN/AN/A$0.00$403.73M0.003,280 Related Companies and Tools Related Companies AVHIW Alternatives AVHIU Alternatives AONC Alternatives BTTX Alternatives DHACW Alternatives CORBF Alternatives LFMDP Alternatives OTRKP Alternatives PIIIW Alternatives SHCRW Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ACONW) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aclarion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aclarion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.